Anais Potron

Dr. Anais Potron

French National Reference Center for antibiotic resistance, CHU de Besançon, UMR 6249 (CNRS – Université de Franche-Comté), Besançon, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2022 in mBio
Verified
Journal Article
Open access
AGAnne-Sophie Godeux
Anne-Sophie Godeux
ESElin Svedholm
Elin Svedholm
SBSamuel Barreto
Samuel Barreto
APAnais Potron
Anais Potron
SVSamuel Venner
Samuel Venner
MLMaria-Halima Laaberki
Maria-Halima Laaberki
Acinetobacter baumannii is a multidrug-resistant pathogen responsible for difficult-to-treat hospital-acquired infections. Understanding the mechanisms leading to the emergence of the multidrug resistance in this pathogen today is crucial.

1 September 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
APAnais Potron
Anais Potron
DFDamien Fournier
Damien Fournier
CECécile Emeraud
Cécile Emeraud
PTPauline Triponney
Pauline Triponney
PPPatrick Plésiat
Patrick Plésiat
Laurent DORTETLaurent DORTET
Laurent DORTET
The immunochromatographic assay NG-Test Carba 5 (NG-Biotech) was evaluated with a collection of 107 carbapenemase-producing nonfermenters (CP-NF) (55 Pseudomonas spp., 51 Acinetobacter spp., and 1 Achromobacter xylosoxidans isolate) and 61 carbapenemase-negative isolates. All KPC, VIM, and NDM carbapenemase producers tested were accurately detected. Of the 16 IMP variants tested, 6 (37.5%) variants were not detected.

14 June 2019 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
APAnais Potron
Anais Potron
JVJean-Baptiste Vuillemenot
Jean-Baptiste Vuillemenot
HPHélène Puja
Hélène Puja
PTPauline Triponney
Pauline Triponney
MBMaxime Bour
Maxime Bour
PPPatrick Plésiat
Patrick Plésiat
Background: Colistin resistance in Acinetobacter baumannii often results from mutational activation of the two-component system PmrAB and subsequent addition of phospho-ethanolamine (pEtN) to lipooligosaccharide by up-regulated pEtN transferase PmrC.Objectives: To characterize mechanisms of colistin resistance independent of PmrCAB in A. baumannii.Methods: Twenty-seven colistin-resistant A. baumannii were collected from 2012 to 2018. Analysis of operon pmrCAB was performed by PCR and sequencing. Seven strains were investigated further by WGS and whole-genome MLST (wgMLST).Results: Seven out of the 27 selected isolates were found to overexpress eptA, a gene homologous to pmrC, likely as a consequence of upstream insertion of an ISAba1 element. Insertion sites of ISAba1 were mapped 13, 18 and 156 bp ahead of the start codon of eptA in five strains, one strain and one strain, respectively. The finding that the isolates did not cluster together when compared by wgMLST analysis supports the notion that distinct insertion events occurred in close, but different, genetic backgrounds.Conclusions: Activation of eptA and subsequent addition of pEtN to the cell surface represents a novel mechanism of resistance to colistin in A. baumannii.

1 June 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
APAnais Potron
Anais Potron
DHDidier Hocquet
Didier Hocquet
PTPauline Triponney
Pauline Triponney
PPPatrick Plésiat
Patrick Plésiat
XBXavier Bertrand
Xavier Bertrand
BVBenoit Valot
Benoit Valot
Nineteen Proteus mirabilis isolates producing the carbapenemase OXA-23 were recovered over a 2-year period in 19 French hospitalized patients, of whom 12 had community onset infections. The isolates exhibited a slightly reduced susceptibility to carbapenems.

28 August 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
SGSusie Gaillot
Susie Gaillot
SOSaoussen Oueslati
Saoussen Oueslati
JVJean-Baptiste Vuillemenot
Jean-Baptiste Vuillemenot
MBMaxime Bour
Maxime Bour
BIBogdan I. Iorga
Bogdan I. Iorga
APAnais Potron
Anais Potron
Here, we characterized the first French NDM-9-producing Acinetobacter baumannii isolate. A. baumannii 13A297, which belonged to the STPas25 (international clone IC7), was highly resistant to β-lactams including cefiderocol (MIC >32 mg/L). Whole genome sequencing (WGS) using both Illumina and Oxford Nanopore technologies revealed a 166-kb non-conjugative plasmid harboring a blaNDM-9 gene embedded in a Tn125 composite transposon. Complementation of E. coli DH5α and A. baumannii CIP70.10 strains with the pABEC plasmid carrying the blaNDM-1 or blaNDM-9 gene, respectively, resulted in a significant increase in cefiderocol MIC values (16 to >256-fold), particularly in the NDM-9 transformants. Interestingly, steady-state kinetic parameters, measured using purified NDM-1 and NDM-9 (Glu152Lys) enzymes, revealed that the affinity for cefiderocol was 3-fold higher for NDM-9 (Km = 53 μM) than for NDM-1 (Km = 161 μM), leading to a 2-fold increase in catalytic efficiency for NDM-9 (0.13 and 0.069 μM−1.s−1, for NDM-9 and NDM-1, respectively). Finally, we showed by molecular docking experiments that the residue 152 of NDM-like enzymes plays a key role in cefiderocol binding and resistance, by allowing a strong ionic interaction between the Lys152 residue of NDM-9 with both the Asp223 residue of NDM-9 and the carboxylate group of the R1 substituent of cefiderocol.

15 February 2022 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
ALAmélie Lombes
Amélie Lombes
RBRémy A. Bonnin
Rémy A. Bonnin
FLFrédéric Laurent
Frédéric Laurent
HGHélène Guet-Revillet
Hélène Guet-Revillet
EBEmmanuelle Bille
Emmanuelle Bille
Laurent DORTETLaurent DORTET
Laurent DORTET
In this multicentric study performed in 12 French hospitals, we reported that 26.9% (14/52) of the amoxicillin-clavulanate-resistant Proteus mirabilis isolates produced the OXA-23 carbapenemase. We found that an inhibition zone diameter of <11 mm around the amoxicillin-clavulanate disc was an accurate screening cutoff to detect these OXA-23 producers.